Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFiglioli, Gisella
dc.contributor.authorBogliolo, Massimo
dc.contributor.authorCatucci, Irene
dc.contributor.authorCaleca, Laura
dc.contributor.authorLasheras, Sandra Viz
dc.contributor.authorPujol, Roser
dc.contributor.authorBalmaña Gelpí, Judith
dc.contributor.authorDiez Gibert, Orland
dc.date.accessioned2021-03-23T14:42:57Z
dc.date.available2021-03-23T14:42:57Z
dc.date.issued2019-11-01
dc.identifier.citationFiglioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. npj Breast Cancer. 2019 Dec 1;5(1):1–14.
dc.identifier.issn2374-4677
dc.identifier.urihttps://hdl.handle.net/11351/5790
dc.descriptionCàncer de mama; Genètica del càncer
dc.description.sponsorshipPeterlongo laboratory is supported by Associazione Italiana Ricerca sul Cancro (AIRC; IG2015 no.16732) to P. Peterlongo and by a fellowship from Fondazione Umberto Veronesi to G. Figlioli. Surrallés laboratory is supported by the ICREA-Academia program, the Spanish Ministry of Health (projects FANCOSTEM and FANCOLEN), the Spanish Ministry of Economy and Competiveness (projects CB06/07/0023 and RTI2018-098419-B-I00), the European Commission (EUROFANCOLEN project HEALTH-F5-2012-305421 and P-SPHERE COFUND project), the Fanconi Anemia Research Fund Inc, and the “Fondo Europeo de Desarrollo Regional, una manera de hacer Europa” (FEDER). CIBERER is an initiative of the Instituto de Salud Carlos III, Spain.
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.ispartofseriesnpj Breast Cancer;5
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMama - Càncer
dc.subjectCàncer - Aspectes genètics
dc.subject.meshTriple Negative Breast Neoplasms
dc.subject.mesh/genetics
dc.titleThe FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41523-019-0127-5
dc.subject.decsneoplasias de mama triple negativos
dc.subject.decs/genética
dc.relation.publishversionhttps://www.nature.com/articles/s41523-019-0127-5
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Figlioli G, Catucci I] IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy. [Bogliolo M, Pujol R] Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain. Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain. [Caleca L] Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy. [Lasheras SV] Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [Balmaña J] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Diez O] Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Genètica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid31700994
dc.identifier.wos000493912600001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-098419-B-I00
dc.relation.projectidinfo:eu-repo/grantAgreement/EC/FP7/HEALTH-F5-2012-305421
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple